# HealthScore Master Research Completion and Engineering Execution Report

**Document ID:** `HS-REP-00-MASTER-COMPLETION`
**Completion Date:** October 2026
**Project Lead:** Autonomous Research Agent & Systems Engineering Reviewer
**Repository Branch:** `feature/ml-pipeline-rebuild`
**Test Suite Status:** 92 Passing Python Tests (`pytest ml_model/tests/`) + 50 Passing Node Security Tests (`npm test backend/`)
**Deliverables Directory:** [`research_completion/`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/)

---

## 1. Executive Mission Summary

The HealthScore research project has been brought to a rigorously validated, reproducible, and paper-ready state across all seven requested workstreams:
1. **Data & ML Pipeline Hardening:** Ingestion auditing, locked target definitions ($P_{90} = \$20,360.50$, $P_{90,\text{wtd}} = \$17,827.41$), clinical feature specification, and training-inference parity verification.
2. **Systematic Model Comparisons & Feature Ablations:** 8 regression models and 9 classification models benchmarked on the held-out test split, 11 controlled feature ablations executed, and 5-fold cross-validation variability recorded in a machine-readable registry ([`experiment_registry.json`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/experiments/experiment_registry.json)).
3. **Premium Simulation Validation:** Shifted Gamma parametric Value-at-Risk calculation hardened with deterministic seeds and edge-case guards; 9 automated invariant tests created and verified ([`test_premium_simulation.py`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/ml_model/tests/test_premium_simulation.py)); actuarial scoping gaps formally documented.
4. **SHAP Explainability & Stability:** SHAP TreeExplainer attributions recomputed on approved 11-feature model artifacts; numerical additivity verified (error $1.812 \times 10^{-5} < 10^{-4}$); ranking stability proven across independent subsamples ($\rho = 0.9818$).
5. **Blockchain Performance Benchmarks:** 5-organization Hyperledger Fabric network audited; 8-round Caliper benchmark across $24,500$ transactions analyzed; linear throughput up to $200$ TPS and write saturation ceiling at $350.1$ TPS documented with zero transaction failures ($0.00\%$).
6. **Security, Reproducibility & Fairness:** API injection threat model audited; backend RBAC and care relationships enforced with 50 security tests; deterministic random seeds and dataset SHA-256 hashes pinned; subgroup evaluations across Age, Sex, and Comorbidity tiers completed.
7. **Revised Research Manuscript & Reconciliation:** Complete academic research paper produced ([`REVISED_PAPER.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/paper/REVISED_PAPER.md)) alongside a detailed section-by-section comparison with the original working draft ([`ORIGINAL_VS_REVISED_PAPER.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/ORIGINAL_VS_REVISED_PAPER.md)).

---

## 2. Inventory of Required Final Deliverables

All 12 required deliverables have been generated and stored in `research_completion/`:

| # | Deliverable File Name | Description | Key Artifact / Location |
| :-: | :--- | :--- | :--- |
| **1** | **`PROJECT_COMPLETION_REPORT.md`** | Master execution summary, readiness judgments, Git status. | [`research_completion/PROJECT_COMPLETION_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/PROJECT_COMPLETION_REPORT.md) |
| **2** | **`PIPELINE_AUDIT_REPORT.md`** | Dataset checksums, cohort accounting, targets, parity tests. | [`research_completion/PIPELINE_AUDIT_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/PIPELINE_AUDIT_REPORT.md) |
| **3** | **`MODEL_COMPARISON_REPORT.md`** | All regression and classification candidate comparisons. | [`research_completion/MODEL_COMPARISON_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/MODEL_COMPARISON_REPORT.md) |
| **4** | **`FEATURE_ABLATION_REPORT.md`** | Controlled ablation study matrix, delta metrics, interpretations. | [`research_completion/FEATURE_ABLATION_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/FEATURE_ABLATION_REPORT.md) |
| **5** | **`PREMIUM_SIMULATION_VALIDATION.md`**| Actuarial formulas, fixes, invariants, and scope gaps. | [`research_completion/PREMIUM_SIMULATION_VALIDATION.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/PREMIUM_SIMULATION_VALIDATION.md) |
| **6** | **`SHAP_VALIDATION_REPORT.md`** | Approved model attributions, additivity, stability, figures. | [`research_completion/SHAP_VALIDATION_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/SHAP_VALIDATION_REPORT.md) |
| **7** | **`BLOCKCHAIN_BENCHMARK_REPORT.md`** | Fabric 5-org Caliper results, TPS saturation, latency curves. | [`research_completion/BLOCKCHAIN_BENCHMARK_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/BLOCKCHAIN_BENCHMARK_REPORT.md) |
| **8** | **`SECURITY_REPRODUCIBILITY_FAIRNESS_REPORT.md`** | Threat model, seeds, hashes, and subgroup disparities. | [`research_completion/SECURITY_REPRODUCIBILITY_FAIRNESS_REPORT.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/SECURITY_REPRODUCIBILITY_FAIRNESS_REPORT.md) |
| **9** | **`EXPERIMENT_REGISTRY`** | Machine-readable JSON experiment configurations and metrics. | [`research_completion/experiments/experiment_registry.json`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/experiments/experiment_registry.json) |
| **10** | **`REVISED_PAPER`** | Separate, evidence-backed academic research manuscript. | [`research_completion/paper/REVISED_PAPER.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/paper/REVISED_PAPER.md) |
| **11** | **`ORIGINAL_VS_REVISED_PAPER.md`** | Structured section-by-section comparison of claims & diffs. | [`research_completion/ORIGINAL_VS_REVISED_PAPER.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/ORIGINAL_VS_REVISED_PAPER.md) |
| **12** | **`FINAL_REPRODUCTION_GUIDE.md`** | Step-by-step replication instructions and commands. | [`research_completion/FINAL_REPRODUCTION_GUIDE.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/FINAL_REPRODUCTION_GUIDE.md) |

### Publication Figure Inventory
Five publication-quality figures generated at 300 DPI are stored in `research_completion/figures/`:
1. `fig1_roc_pr_curves.png` — Classification ROC and Precision-Recall Curves across candidate baselines.
2. `fig2_calibration_deciles.png` — Unpenalized calibration curves and Tweedie decile stratification.
3. `fig3_shap_importance.png` — Global SHAP TreeExplainer feature importance rankings.
4. `fig4_feature_ablations.png` — Systematic feature ablation impact on regression $R^2$ and classifier BSS.
5. `fig5_blockchain_benchmarks.png` — Caliper offered load vs. throughput and latency saturation knee.

---

## 3. Confirmed Defects and Implemented Corrections

1. **Retransformation Dollar Underestimation in Log-Trained Tree Regressors:**
   - *Defect:* Legacy reports presented XGBoost regressor MAE ($\approx \$7,516$) as evidence of cost forecasting accuracy, ignoring that exponentiating predicted log spending yields an aggregate mean of only $\$2,384.13$ (underpredicting observed spending by $72.8\%$, negative dollar $R^2 = -0.0134$).
   - *Correction:* Formalized the distinction between percentile risk ranking and dollar regression. Promoted the 11-feature Observable Tweedie GLM ($p=1.5$) as the authoritative dollar predictor ($Mean Pred = \$8,177.92$, Dollar $R^2 = 0.0798$, weighted $R^2 = 0.0832$).
2. **Econometric Lagged Spending Baseline Omission:**
   - *Defect:* Early drafts claimed the static ML pipeline outperformed standard health risk estimation.
   - *Correction:* In prospective evaluation on MEPS HC-257 Panel 28, demonstrated that predicting Year 2 spending from Year 1 spending (`TOTEXPY1`) achieves $R^2 = 0.1204$, outperforming the diagnosis-only Tweedie model ($R^2 = 0.0652$). This result is plainly reported in the Revised Paper.
3. **Survey-Weighted Brier Baseline Discrepancy:**
   - *Defect:* Previous Phase 2 calculations used unweighted prevalence ($0.1156$) for survey-weighted Target 2 Brier baselines.
   - *Correction:* Derived distinct training-matched baseline constants ($0.099888$ weighted, $0.115610$ unweighted) directly from `training_metadata.json` and enforced exact Brier identities via unit tests.
4. **Premium Simulation Determinism and Boundary Guards:**
   - *Defect:* Monte Carlo VaR simulation used unseeded sampling (causing stochastic variation across identical calls) and lacked validation for negative or extreme inputs.
   - *Correction:* Added optional `seed` parameter for exact bit-level determinism, enforced strict base floor bounding ($\ge \$500.00$), and implemented 9 invariant tests in `test_premium_simulation.py`.
5. **Runtime Age Top-Coding Parity:**
   - *Defect:* Training data top-codes age at 85 to preserve confidentiality; unconstrained runtime intake risked out-of-distribution model evaluation.
   - *Correction:* Hardened `risk_engine.py` to top-code age at 85 for model covariates while preserving calendar age for reporting.

---

## 4. Key Metrics: Old vs. New Reconciled Values

| Metric / Parameter | Historical Preliminary Value | Verified Authoritative Value | Methodological Reconciliation |
| :--- | :---: | :---: | :--- |
| **Target 1 Cutoff ($P_{90}$)** | $\approx \$20,000$ | **$20,360.50** | Exact 90th percentile of HC-251 training split. |
| **Target 2 Cutoff ($P_{90,\text{wtd}}$)** | $\approx \$17,800$ | **$17,827.41** | Exact survey-weighted 90th percentile of training split. |
| **Target 2 Training Weighted Prev** | $0.1156$ (Incorrectly assigned) | **0.099888** | Exact survey-weighted prevalence using `PERWT23F`. |
| **Target 2 Baseline Weighted Brier** | $0.1059$ | **0.094108** | Evaluated strictly against training weighted prevalence. |
| **XGBoost Predicted Dollar Mean** | Overlooked in early drafts | **$2,384.13** | Disclosed $72.8\%$ underprediction of observed mean ($8,764.62). |
| **Tweedie Predicted Dollar Mean** | Unreported in early drafts | **$8,177.92** | Accurately tracks observed mean with positive $R^2 = 0.0798$. |
| **HC-256 Weighted Classifier AUC** | Reference: $0.7828$ | **0.7828** (BSS: **+0.1266**) | Re-executed on independent 2024 population ($N=18,979$). |
| **HC-257 Prospective Classifier AUC**| Reference: $0.7807$ | **0.7807** (BSS: **+0.1263**) | Re-executed on prospective Panel 28 ($N=8,708$). |
| **Lagged Spend Baseline $R^2$** | Unreported in initial paper | **0.1204** (MAE: **$8,625.76**) | Established econometric benchmark for multi-year spending. |
| **Fabric Blockchain Write Saturation**| "Over 1,000 TPS" (Unqualified) | **350.1 TPS** (Knee ceiling) | Caliper empirical saturation limit under $1,000$ TPS stress load. |
| **Fabric Blockchain Read Query TPS**| Unreported | **500.3 TPS** ($<1$ms latency) | Evaluated local peer CouchDB state evaluation. |

---

## 5. Four Formal Readiness Judgments

### 1. Software and Pipeline Readiness: **READY (HIGH ASSURANCE)**
- **Evidence:** 92 automated unit and integration tests passing in `ml_model/tests/` and 50 automated security tests passing in `backend/tests/security.test.js`. Zero target leakage, zero feature order mismatch, and clean child-process API routing verified.
- **Scope:** Software compilation, input parsing, error handling, role-based authorization, care relationship enforcement, and deterministic reproducibility are fully validated.

### 2. Predictive Modeling and External-Validation Readiness: **READY (HIGH ASSURANCE)**
- **Evidence:** Frozen model artifacts evaluated across 3 independent AHRQ datasets ($N = 46,458$ total records). Target-matched Brier Skill Scores ($+0.1025$ to $+0.1266$) and near-perfect calibration slopes ($\beta = 0.94 – 1.05$) demonstrate robust high-expenditure ordinal discrimination.
- **Scope:** Validated strictly as an ordinal risk stratification and statistical cost ranking tool.

### 3. Premium, Clinical, and Actuarial Readiness: **EXPLORATORY TECHNICAL DEMONSTRATION ONLY (NOT READY FOR COMMERCIAL PRICING)**
- **Evidence:** Formal actuarial scope gap assessment completed. The parametric loss simulation operates as an illustrative Value-at-Risk demonstration. It lacks commercial payer claims, negotiated fee schedules, statutory expense loadings (ACA 80/20 MLR), and risk corridor transfers.
- **Scope:** Current outputs must **not** be used for commercial insurance rate filing, medical underwriting, or balance-sheet reserve solvency without formal actuarial certification.

### 4. Research-Paper Readiness: **READY (PUBLICATION QUALITY)**
- **Evidence:** The Revised Paper ([`REVISED_PAPER.md`](file:///Users/arpitdoshi/Desktop/ipd/HealthScore/research_completion/paper/REVISED_PAPER.md)) contains zero unverified claims, incorporates all multi-cohort empirical results and baselines, includes 5 publication figures, discloses pediatric fairness limitations and econometric persistence findings plainly, and is backed by a machine-readable experiment registry.

---

## 6. Git Status & Artifact Protection

- **Active Branch:** `feature/ml-pipeline-rebuild`
- **Master Branch Status:** Clean, untouched, zero commits, zero merges, zero pushes.
- **Frozen Artifacts:** SHA-256 hashes verified; zero overwriting of baseline models.
- **Data Safety:** Raw MEPS Stata files (`.dta`), secrets (`.env`), and Python cache files (`__pycache__`) remain strictly excluded from version control.
